Neurol. praxi. 2010;11(4):244-249

Pharmacotherapy of advanced Parkinson’s disease with respect to the guidelines

prof.MUDr.Petr Kaňovský, CSc., MUDr.Kateřina Farníková
Centrum pro diagnostiku a léčbu neurodegenerativních onemocnění
Neurologická klinika LF UP a FN, Olomouc

The therapeutic guidelines for Parkinson’s disease have been developed for more than 15 years. Due to improved recognition of the

symptoms of the disease and extended therapeutic options, the original short and brief guidelines have been replaced by multipart

guidelines that separately deal with motor and non-motor symptoms of Parkinson’s disease. Currently, there are both European and

American variants of therapeutic guidelines which serve as guidance, but not an obligatory one; their application has to be creative and

respect individual features of the disease in a particular patient.

Keywords: Parkinson’s disease, guidelines

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kaňovský P, Farníková K. Pharmacotherapy of advanced Parkinson’s disease with respect to the guidelines. Neurol. praxi. 2010;11(4):244-249.
Download citation

References

  1. Horstink M, Tolosa E, Bonucelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C. Review of the therapeutic management of Parkinson´s disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society - European Section (MDS-ES). Part II: late (complicated) Parkinson´s disease. Eur J Neurol 2006; 13: 1186-1202. Go to original source... Go to PubMed...
  2. Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, Shulman LM, Gronseth G, Weiner WJ. Practice parameter: evaluation and treatment of depression, psychosis and dementia in Parkinsons´disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 66: 996-1002. Go to original source... Go to PubMed...
  3. Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson´s disease: treatment guidelines. American Academy of Neurology. Neurology 1998; 50(suppl. 3): S1-S7. Go to original source... Go to PubMed...
  4. Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ. Practice parameter: treatment of Parkinson´s disease with motor fluctuations and dyskinesia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 66: 983-995. Go to original source... Go to PubMed...
  5. Růžička E, Roth J. Parkinsonova nemoc: přehled léčebných postupů. Čes. Slov Neurol. Neurochir. 1998; 61(suppl. 1): 1-16.
  6. Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri, KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Werner WJ. Practice parameter: treatment of nonmotor symptoms of Parkinson´s disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010; 74: 924-931. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.